𝛼SK or Search

ENTITY

Regent Pacific (575 HK)

2

Analysis

Health Care • Hong Kong

Regent Pacific is an investment holding company focused on the healthcare and life sciences sectors. It engages in the research, development, manufacturing, marketing, and sale of pharmaceutical products for urological disorders, such as Fortacin™/Senstend™, and develops AI systems for biological aging clocks through Deep Longevity. The company was founded in 1991 and is headquartered in Central, Hong Kong.

more

Refresh

Exchange Announcement • 28 Sep 2026 18:12

Voluntary Announcement - Launch Of Accrua - Deep Longevity'S Consumer Digital Health Platform In The United States

Exchange Announcement • 21 Sep 2026 16:39

Notification Letter To Non-Registered Shareholders And Request Form

Exchange Announcement • 21 Sep 2026 16:37

Notification Letter To Registered Shareholders And Change Request Form

Exchange Announcement • 21 Sep 2026 16:35

2026 Interim Report

Exchange Announcement • 01 Sep 2026 19:48

Voluntary Operational Update - Receipt Of Payment From Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd. And Update On Senstend Commercialisation In The Prc

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x